vs

Side-by-side financial comparison of KURA SUSHI USA, INC. (KRUS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $73.5M, roughly 1.1× KURA SUSHI USA, INC.). KURA SUSHI USA, INC. runs the higher net margin — -4.2% vs -38.1%, a 33.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 14.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 13.2%).

Kura Sushi, Inc. is a Japanese conveyor belt sushi restaurant chain. It is the second largest sushi restaurant chain in Japan, behind Sushiro and ahead of Hama Sushi. Its headquarters are in Sakai, Osaka Prefecture. It has 543 locations in Japan, 56 in Taiwan, and 69 in the United States.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

KRUS vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$73.5M
KRUS
Growing faster (revenue YoY)
PRCT
PRCT
+6.2% gap
PRCT
20.2%
14.0%
KRUS
Higher net margin
KRUS
KRUS
33.9% more per $
KRUS
-4.2%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
13.2%
KRUS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
KRUS
KRUS
PRCT
PRCT
Revenue
$73.5M
$83.1M
Net Profit
$-3.1M
$-31.6M
Gross Margin
64.9%
Operating Margin
-5.0%
-4.1%
Net Margin
-4.2%
-38.1%
Revenue YoY
14.0%
20.2%
Net Profit YoY
-218.4%
-27.9%
EPS (diluted)
$-0.25
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRUS
KRUS
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$73.5M
$76.4M
Q3 25
$79.4M
$83.3M
Q2 25
$74.0M
$79.2M
Q1 25
$64.9M
$69.2M
Q4 24
$64.5M
$68.2M
Q3 24
$66.0M
$58.4M
Q2 24
$63.1M
$53.4M
Net Profit
KRUS
KRUS
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-3.1M
$-29.8M
Q3 25
$2.3M
$-21.4M
Q2 25
$565.0K
$-19.6M
Q1 25
$-3.8M
$-24.7M
Q4 24
$-961.0K
$-18.9M
Q3 24
$-5.2M
$-21.0M
Q2 24
$-558.0K
$-25.6M
Gross Margin
KRUS
KRUS
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
KRUS
KRUS
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-5.0%
-40.6%
Q3 25
1.8%
-27.8%
Q2 25
-0.2%
-28.0%
Q1 25
-7.1%
-39.7%
Q4 24
-2.3%
-28.9%
Q3 24
-8.8%
-38.4%
Q2 24
-1.9%
-50.3%
Net Margin
KRUS
KRUS
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-4.2%
-39.1%
Q3 25
2.9%
-25.7%
Q2 25
0.8%
-24.7%
Q1 25
-5.8%
-35.8%
Q4 24
-1.5%
-27.6%
Q3 24
-7.9%
-35.9%
Q2 24
-0.9%
-48.0%
EPS (diluted)
KRUS
KRUS
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.25
$-0.54
Q3 25
$0.18
$-0.38
Q2 25
$0.05
$-0.35
Q1 25
$-0.31
$-0.45
Q4 24
$-0.08
$-0.34
Q3 24
$-0.47
$-0.40
Q2 24
$-0.05
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRUS
KRUS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$50.7M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$229.2M
$347.7M
Total Assets
$443.5M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRUS
KRUS
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$50.7M
$286.5M
Q3 25
$62.5M
$294.3M
Q2 25
$60.5M
$302.7M
Q1 25
$85.2M
$316.2M
Q4 24
$107.7M
$333.7M
Q3 24
$51.0M
$196.8M
Q2 24
$60.7M
$214.1M
Total Debt
KRUS
KRUS
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
KRUS
KRUS
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$229.2M
$365.9M
Q3 25
$231.1M
$380.3M
Q2 25
$227.0M
$385.8M
Q1 25
$225.0M
$389.2M
Q4 24
$227.6M
$402.2M
Q3 24
$162.5M
$241.2M
Q2 24
$166.4M
$251.8M
Total Assets
KRUS
KRUS
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$443.5M
$508.1M
Q3 25
$430.9M
$511.5M
Q2 25
$419.4M
$513.1M
Q1 25
$410.4M
$519.4M
Q4 24
$403.8M
$534.0M
Q3 24
$328.5M
$374.1M
Q2 24
$324.7M
$374.4M
Debt / Equity
KRUS
KRUS
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRUS
KRUS
PRCT
PRCT
Operating Cash FlowLast quarter
$529.0K
Free Cash FlowOCF − Capex
$-13.3M
FCF MarginFCF / Revenue
-18.1%
Capex IntensityCapex / Revenue
18.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRUS
KRUS
PRCT
PRCT
Q1 26
Q4 25
$529.0K
$-10.3M
Q3 25
$9.4M
$-6.6M
Q2 25
$6.7M
$-15.0M
Q1 25
$4.3M
$-17.0M
Q4 24
$4.4M
$-32.4M
Q3 24
$669.0K
$-18.8M
Q2 24
$8.7M
$-15.7M
Free Cash Flow
KRUS
KRUS
PRCT
PRCT
Q1 26
Q4 25
$-13.3M
$-12.2M
Q3 25
$-79.0K
$-9.5M
Q2 25
$-6.9M
$-17.8M
Q1 25
$-7.3M
$-18.8M
Q4 24
$-7.2M
$-33.6M
Q3 24
$-9.6M
$-19.0M
Q2 24
$-2.4M
$-16.8M
FCF Margin
KRUS
KRUS
PRCT
PRCT
Q1 26
Q4 25
-18.1%
-15.9%
Q3 25
-0.1%
-11.4%
Q2 25
-9.3%
-22.5%
Q1 25
-11.2%
-27.2%
Q4 24
-11.2%
-49.2%
Q3 24
-14.6%
-32.6%
Q2 24
-3.8%
-31.4%
Capex Intensity
KRUS
KRUS
PRCT
PRCT
Q1 26
Q4 25
18.8%
2.4%
Q3 25
11.9%
3.4%
Q2 25
18.4%
3.5%
Q1 25
17.8%
2.7%
Q4 24
17.9%
1.7%
Q3 24
15.6%
0.4%
Q2 24
17.6%
2.0%
Cash Conversion
KRUS
KRUS
PRCT
PRCT
Q1 26
Q4 25
Q3 25
4.12×
Q2 25
11.88×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRUS
KRUS

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons